6. ….things are changing……
Emerging markets are evolving faster
Vaccine manufacturers expanding their
capabilities to address need of emerging market
7. • Need to increase the immunization
coverage rates for both pediatric and
adolescents / adults vaccines
• Huge demand for traditional/ classical
vaccines, low cost but high volume
demand
8. Growth in emerging countries can happen by
- Building production capacity
- Matching global quality standards
9. The challenge…..
• Vaccine manufacturing is
- critical and complex
- requires capital-intensive capabilities
- high GMP standards